Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659)

Name: Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659)
License: Public Domain

Merck Sharp & Dohme LLC

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

gastric-cancer

gastric cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 268032
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.